Investigating the nature of co-occurring depression and anxiety: Comparing diagnostic and dimensional research approaches

• Published in: Journal of affective disorders Vol. 216; pp. 123 - 135
• Main Authors: Kircanski, Katharina, LeMoult, Joelle, Ordaz, Sarah, Gotlib, Ian H
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.07.2017
• Subjects: Adult; Anxiety; Anxiety Disorders - diagnosis; Anxiety Disorders - psychology; Comorbidity; Cortisol; Depression; Depressive Disorder - diagnosis; Depressive Disorder - psychology; Female; Humans; Male; Middle Aged; Psychiatry; Symptom Assessment - methods; Symptom dimension; Depression; Anxiety; Cortisol; Comorbidity; Symptom dimension
• ISSN: 0165-0327; 1573-2517
• DOI: 10.1016/j.jad.2016.08.006

Abstract Background Although approximately half of adults diagnosed with a depressive or anxiety disorder exhibit their simultaneous co-occurrence, traditional research has centered on single-target diagnoses, overlooking comorbidities within samples. In this article, we review and extend the literature that directly investigates co-occurring depression and anxiety, with the goal of shifting the focus from co-occurring diagnoses to symptom dimensions. Methods First, we review studies that have directly compared psychobiological features (neural, neuroendocrine, autonomic) across depression, anxiety, and their co-occurrence, defined either categorically or dimensionally. Second, we analyze adults’ diurnal cortisol secretion to examine the independent and interactive relations of continuously-assessed depressive and anxiety symptoms to neuroendocrine function. Results Previous findings on the psychobiology of diagnostic co-occurrence are mixed. While nascent, evidence from dimensionally focused studies suggests that co-occurring levels of depressive and anxiety symptoms can interact with one another, as reflected in a distinct psychobiological profile for individuals with high levels of both symptom dimensions. Results of our analyses support this formulation: we found that depressive and anxiety symptom dimensions interacted consistently in their relation to the measures of diurnal cortisol. Limitations The illustrative sample was relatively small and included only women; future research should examine generalizability of these findings. Conclusions A dimensional approach to investigating the psychobiology of co-occurring depression and anxiety affords both conceptual and practical advantages. Simultaneously assessing depressive and anxiety symptom dimensions can efficiently capture their unique, shared, and interactive features, thereby identifying targets for intervention across a wide range of symptom presentations.